Wird geladen...
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record
OBJECTIVE: Recently, the European Medicines Agency reported that strontium ranelate increases myocardial infarction risk in postmenopausal women, 8.5 years after it was registered for use in osteoporosis. Unreported serious adverse events in clinical trials for other pharmaceuticals have been descri...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187454/ https://ncbi.nlm.nih.gov/pubmed/25293384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005787 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|